In a new analysis of Phase 2 and 3 anifrolumab (Saphnelo®) clinical trial data, researchers found that the SLE Disease ...

This webinar connects people living with lupus, their care partners, and the broader community directly to Phase III clinical ...

National Lupus Advocacy Summit brings powerful voices to Capitol Hill to advocate for all Americans living with lupus. Hundreds of lupus advocates from 42 states gathered in Washi ...

The U.S. Food and Drug Administration (FDA) has accepted Genentech’s supplemental Biologics License Application for Gazyva® ...

If you have a parent, sibling, or child diagnosed with lupus — but you do not have lupus yourself — you may be eligible to participate in CARE Lupus. Lupus has long been treated after symptoms begin - ...

May is Lupus Awareness Month! Rally your family, friends and community to raise funds and awareness of the invisible physical, emotional and financial impact of lupus. Help us continue to advocate, ...

The Lupus Foundation of America’s (LFA) Community Health Worker (CHW) hub was created to increase awareness of lupus and knowledge of resources available. The CHW hub features on-demand learning ...

People with lupus can have cognitive symptoms, like having a hard time thinking clearly or remembering things. This is also called “brain fog” or “lupus fog,” and it often comes and goes over time. In ...

The Lupus Foundation of America’s Game On! to End Lupus unites content creators from around the world to use their platforms to help end lupus. Held over a three-day period in May and throughout Lupus ...

Join lupus warriors and advocates from across the country for the largest lupus advocacy event of the year! The 2026 National Lupus Advocacy Summit will take place April 19-21 in Washington, D.C. and ...

How does lupus impact Asian Americans? People of all races and ethnic groups can develop lupus, but lupus is more common among Asian Americans than in the general population. This appears to be true ...

A new study found that low levels of 25-Hydroxyvitamin D levels are associated with significantly higher mortality and cardiovascular events in individuals with systemic lupus erythematosus (SLE).